Gene-Based Risk Scores Predicts Alcoholic Cirrhosis
By LabMedica International staff writers Posted on 23 Jan 2019 |
Image: The CFX384 real-time PCR detection system (Photo courtesy of Bio-Rad Laboratories).
Alcoholic chronic liver disease, with a prevalence of around 12% in the European and North-American populations, is characterized by a broad spectrum of conditions ranging from simple steatosis to alcoholic steatohepatitis, cirrhosis, and hepatocellular carcinoma.
Environmental factors, aging, genetic predisposition, and gender play a pivotal role in alcoholic cirrhosis development and progression. The most established environmental factors influencing the susceptibility to chronic alcohol-related liver damage are represented by dose and pattern of alcohol intake, diet, obesity, diabetes, and smoking.
An international team of clinical and molecular scientists working with The Sahlgrenska Academy (Göteborg, Sweden) retrospectively examined a total of 416 male at-risk alcohol drinkers. The possible presence of cirrhosis was also assessed and the time of cirrhosis diagnosis was reported using data from hospital discharge papers, medical records, physical examination, blood tests, imaging, and endoscopy.
Buffy coat fraction was recovered from whole blood EDTA and DNA extraction was performed using QIAamp DNA Blood Kit. PNPLA3 rs738409, CD14 rs2569190, TM6SF2 rs58542926, and MBOAT7 rs641738 variants were genotyped by TaqMan genotyping assay. Post-polymerase chain reaction (PCR) allelic discrimination was performed on a CFX384 Real-Time System by measuring allele-specific fluorescence.
The team reported that PNPLA3, CD14, and TM6SF2 were associated with alcoholic cirrhosis prevalence. PNPLA3 and CD14 were also associated with its incidence. A threshold of 7.27 was identified as cutoff for the predictive risk of alcoholic cirrhosis development in 36 years from the onset of at-risk alcohol consumption with 70.1% sensitivity and 78.7% specificity. The negative predictive value and the positive predictive value were 90.2% and 48.6%, respectively.
The authors concluded that identifying genetic and environmental candidate factors that confer susceptibility to alcoholic cirrhosis development could potentially inform the clinician on patient management. It would be useful, for clinicians, to predict, since the first visit, the risk over time of alcoholic cirrhosis in male patients with at-risk alcohol consumption and to select a population with a high risk to develop cirrhosis in order to plan a patient-tailored therapy. The study was published on January 10, 2019, in the journal The Application of Clinical Genetics.
Related Links:
The Sahlgrenska Academy
Environmental factors, aging, genetic predisposition, and gender play a pivotal role in alcoholic cirrhosis development and progression. The most established environmental factors influencing the susceptibility to chronic alcohol-related liver damage are represented by dose and pattern of alcohol intake, diet, obesity, diabetes, and smoking.
An international team of clinical and molecular scientists working with The Sahlgrenska Academy (Göteborg, Sweden) retrospectively examined a total of 416 male at-risk alcohol drinkers. The possible presence of cirrhosis was also assessed and the time of cirrhosis diagnosis was reported using data from hospital discharge papers, medical records, physical examination, blood tests, imaging, and endoscopy.
Buffy coat fraction was recovered from whole blood EDTA and DNA extraction was performed using QIAamp DNA Blood Kit. PNPLA3 rs738409, CD14 rs2569190, TM6SF2 rs58542926, and MBOAT7 rs641738 variants were genotyped by TaqMan genotyping assay. Post-polymerase chain reaction (PCR) allelic discrimination was performed on a CFX384 Real-Time System by measuring allele-specific fluorescence.
The team reported that PNPLA3, CD14, and TM6SF2 were associated with alcoholic cirrhosis prevalence. PNPLA3 and CD14 were also associated with its incidence. A threshold of 7.27 was identified as cutoff for the predictive risk of alcoholic cirrhosis development in 36 years from the onset of at-risk alcohol consumption with 70.1% sensitivity and 78.7% specificity. The negative predictive value and the positive predictive value were 90.2% and 48.6%, respectively.
The authors concluded that identifying genetic and environmental candidate factors that confer susceptibility to alcoholic cirrhosis development could potentially inform the clinician on patient management. It would be useful, for clinicians, to predict, since the first visit, the risk over time of alcoholic cirrhosis in male patients with at-risk alcohol consumption and to select a population with a high risk to develop cirrhosis in order to plan a patient-tailored therapy. The study was published on January 10, 2019, in the journal The Application of Clinical Genetics.
Related Links:
The Sahlgrenska Academy
Latest Molecular Diagnostics News
- Urine Test to Revolutionize Lyme Disease Testing
- Simple Blood Test Could Enable First Quantitative Assessments for Future Cerebrovascular Disease
- New Genetic Testing Procedure Combined With Ultrasound Detects High Cardiovascular Risk
- Blood Samples Enhance B-Cell Lymphoma Diagnostics and Prognosis
- Blood Test Predicts Knee Osteoarthritis Eight Years Before Signs Appears On X-Rays
- Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans
- Unique Autoantibody Signature to Help Diagnose Multiple Sclerosis Years before Symptom Onset
- Blood Test Could Detect HPV-Associated Cancers 10 Years before Clinical Diagnosis
- Low-Cost Point-Of-Care Diagnostic to Expand Access to STI Testing
- 18-Gene Urine Test for Prostate Cancer to Help Avoid Unnecessary Biopsies
- Urine-Based Test Detects Head and Neck Cancer
- Blood-Based Test Detects and Monitors Aggressive Small Cell Lung Cancer
- Blood-Based Machine Learning Assay Noninvasively Detects Ovarian Cancer
- Simple PCR Assay Accurately Differentiates Between Small Cell Lung Cancer Subtypes
- Revolutionary T-Cell Analysis Approach Enables Cancer Early Detection
- Single Genetic Test to Accelerate Diagnoses for Rare Developmental Disorders